Prospective study of changes in sugar-sweetened beverages consumption and incidence of metabolic syndrome and its components by Barrio-Lopez, M.T. (Maria T.) et al.
1 
 
Prospective study of changes in sugar-sweetened beverages consumption and 
incidence of metabolic syndrome and its components 
 
Authors: Barrio-Lopez MT
1,2
, Martinez-Gonzalez MA
1
, Fernandez-Montero A
1
, 
Beunza JJ
1
, Zazpe I 
1,3
, Bes-Rastrollo M
1
.   
1
Department of Preventive Medicine and Public Health. School of Medicine, University 
of Navarra, C/Irunlarrea, 1. 31008 Pamplona, Navarra, Spain.  
2
Department of Cardiology and Cardiac Surgery, University Clinic of Navarra, Avenida 
Pio XII, 36. 31008 Pamplona, Navarra, Spain.  
3
Department of Nutrition and Food Sciences, Physiology and Toxicology, School of 
Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Navarra, Spain  
Correspondence author: 
Prof. Miguel Angel Martinez-Gonzalez, MD, MPH, PhD. 
Dept of Preventive Medicine and Public Health, University of Navarra, Ed. 
Investigación. C/Irrunlarrea, 1. 31008 Pamplona, Navarra. Spain. 
Tel: 948 425600 ext. 6463 Fax: 948 455649 E-mail: mamartinez@unav.es 
Keywords: sugar-sweetened beverages; metabolic syndrome; cohort; prospective; 
Acronyms: MS: metabolic syndrome; SSB: sugared-sweetened beverages; IDF: 
International Diabetes Federation; AHA/NHLBI: America Heart Association/ National 
Heart, Lung, and Blood Institute; aOR: adjusted odds ratio; CI: confidence interval; 
SUN: Seguimiento Universidad de Navarra. Follow-up University of Navarra; Q6: 
questionnaire after 6 years of follow-up; Q0: baseline questionnaire; BMI: body mass 
index; FFQ: food frequency questionnaire;TG: triglycerides 
 
*Manuscript
2 
 
Abstract: 
Background and aims: The incidence of the metabolic syndrome (MS) is increasing and 
lifestyle behaviours may play a role in its development. Our aim was to assess 
prospectively the association between changes in sugar-sweetened beverages (SSB) 
consumption and the incidence of the MS and its components in a Spanish cohort of 
university graduates.  
Methods and results: We included 8,157 participants initially free of MS and followed-
up during ≥ 6 years. SSB consumption was collected through a food frequency 
questionnaire previously validated in Spain. Change in SSB consumption was 
calculated as the difference between SSB consumption at 6-year follow-up and the 
baseline consumption. The MS was defined according to the International Diabetes 
Federation and the American Heart Association/ National Heart, Lung, and Blood 
Institute new definition of MS that had harmonized previous definitions. Logistic 
regression models were used to adjust for potential confounders. We observed 361 
incident cases of MS. Participants in the highest quintile of increase in SSB 
consumption presented a significantly higher risk of developing MS (adjusted odds ratio 
(aOR):2.2; 95% confidence interval (CI):1.4-3.4; p for trend 0.006). Similarly, they 
presented a significantly higher risk of developing high blood pressure (aOR:1.7; 95% 
CI:1.4-2.0), central obesity (aOR:1.9; 95% CI: 1.6-2.2); hypertriglyceridemia (aOR:1.6; 
95% CI:1.1-2.2) or impaired fasting glucose (aOR:1.4; 95% CI:1.1-1.9).  
Conclusions: An increase in SSB consumption was associated with higher risk of 
developing the MS and other metabolic disorders after 6 years of follow-up. 
3 
 
Introduction: 
The prevalence of MS in developed countries affects around 25% of the population [1] 
and its incidence has increased over the last years. However, there is an heterogeneous 
distribution of MS across the different regions [2,3] that may be associated with 
lifestyles habits. 
Food habits are an important factor determining MS, but not only food is a source of 
nutrients in the diet. Drinks can be a major source of carbohydrates and some of them 
contain sugar, other sweeteners, alcohol or caffeine [4]. 
Several reports indicated an increasing consumption of SSB among children and adults 
over the past 3 decades [5] and have linked the rising consumption of SSB to an 
increase in obesity and diabetes mellitus among children and adolescents [6] and to the 
development of hypertension and cardiovascular disease
 
[7] in adults. 
Furthermore, SSB consumption have been linked to an increase in serum triglycerides 
levels [8] and a decrease in serum HDL-cholesterol [9].  
Regarding the MS, only three prospective studies have shown a link between SSB 
consumption and the risk of developing the complete MS [10-12]. All of them were 
summarized in a meta-analysis [13]. However, none of these studies have been 
conducted in the context of a Mediterranean dietary pattern where the average 
consumption of SSB is very low in comparison with the United States or North 
European countries. Additionally, all previous studies only assessed baseline 
consumption but not changes in SSB consumption during follow-up.  
The aim of our study was to assess the association between changes in SSB 
consumption and the incidence of MS and its components in a cohort of Spanish 
university graduates. 
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Methods: 
Study Population 
The SUN (Seguimiento Universidad de Navarra) Project is a dynamic prospective 
cohort conducted in Spain with permanently open recruitment and whose participants 
are university graduates who are contacted and followed-up using mailed or web-based 
questionnaires. A description of the study methods has been previously published 
[14,15]. Briefly, beginning in December 1999, all graduates of the University of 
Navarra, registered nurses from some Spanish provinces, and university graduates from 
other colleges and associations received a mailed questionnaire and a letter of invitation 
to participate in the SUN Project. A response to the initial questionnaire was considered 
as informed consent to participate in the study. The project protocol was approved by 
the Institutional Review Board of the University of Navarra. 
After baseline assessment, participants received follow-up questionnaires every two 
years that contained a wide variety of questions on diet, lifestyle, risk factors and 
medical conditions. 
For our MS study, a subsample of the cohort was selected. To warrant a minimum 
follow-up of 6 years, we included only those participants who had completed 
questionnaires up to 6 years of follow-up.14716 SUN participants responded to the 
baseline questionnaire before September 2004. Among them, 3,728 participants were 
excluded because they have one or more criteria for the MS. 1139 with extreme caloric 
intake (<800kcal/d for men, <500 kcal/d for women, >4000 kcal/d for men, or >3500 
kcal/d for women) were also excluded. Among the remaining, 1,136 participants 
answered some follow-up questionnaire but not the 6-year or 8-year follow-up 
questionnaire and 556 did not answered any follow-up questionnaires. Therefore, 8,157 
participants were included in the final analyses (Figure 1).  
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Definition and components of the MS 
We defined MS according to the International Diabetes Federation (IDF) and American 
Heart Association/National Heart, Lung, and Blood Institute new definition of MS that 
has harmonized previous definitions [16]. According to this definition, the diagnosis of 
MS needs the presence of 3 of any of this 5 components: elevated waist circumference 
according to the population and country specific definition (in our study:94 cm in 
males and 80 cm in females), elevated triglycerides (150 mg/dL) or presence of drug 
treatment for elevated triglycerides, reduced HDL-cholesterol (<40 mg/dL in males and 
<50 mg/dL in females) or presence of drug treatment for reduced HDL-cholesterol, 
elevated blood pressure (systolic 130 and/or diastolic 85 mm Hg) or presence of drug 
treatment for hypertension and elevated fasting glucose 100 mg/dL or drug treatment 
of elevated glucose. 
In the 6-year and 8-year follow-up questionnaires, self-reported data about these 
specific MS criteria were collected. A measure tape was sent to all participants with 
these questionnaires including an explanation about how to measure their own waist.  
The validation of the self-reported data of the criteria needed to classify participants into 
MS was assessed in a two different subsamples of the cohort finding significant 
intraclass correlation coefficients between 0.5 to 0.9 (p<0.001) depending on the MS 
criteria [17] and a proportion of confirmed MS of 91.2% (95%CI: 80.7-97.1) and non-
confirmed MS of 92.2% (95%CI: 85.1-96.4) [18].  
Incident cases of MS were defined as those participants who did not have MS at 
baseline and reported criteria of MS in either the 6 or 8-year follow-up questionnaire.  
 
Assessment of dietary and non-dietary exposures. 
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Dietary habits at baseline were assessed using a semi-quantitative food-frequency 
questionnaire (FFQ) with 136 items, previously validated in Spain and recently re-
evaluated
 
[19]. We defined a Mediterranean dietary pattern “a priori” using the score 
proposed by Trichopoulou [20]. The baseline questionnaire also included different 
questions related to lifestyle, sociodemographic variables (sex, age and years of 
university education) anthropometric data, health-related habits (e.g., smoking status, 
alcohol consumption, and physical activity), and medical history information 
(medication use, cholesterol level and blood pressure). The reproducibility and validity 
of the self-reported anthropometrics [21], physical activity questionnaire [22], and the 
diagnosis of hypertension [23] were assessed in sub-samples of the cohort. 
 
Assessment of SSB consumption 
The change in SSB consumption was calculated as the difference between SSB drink 
consumption in the 6-year follow up (Q6) questionnaire and the baseline consumption 
(Q0). This difference in consumption was classified in quintiles of change (quintile 1 
for those participants who decreased the most their consumption and quintile 5 for those 
participants who increased the most their consumption), considering the first quintile as 
the reference category.  
 
Statistical analysis 
The cumulative incidence of MS was computed for each quintile of change in SSB 
consumption. To avoid the confounding effect of other variables simultaneously 
associated with the outcome and the main exposure, we used non-conditional logistic 
regression models. 
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We also assessed the association between quintiles of change of SSB consumption and 
each criteria for the MS. Linear trend tests were calculated using the median change of 
SSB consumption of each quintile and introducing this new variable as a continuous one 
in the models.  
We evaluated effect modification through likelihood ratio tests for the product-term 
introduced in fully-adjusted models.  
As secondary analyses we assessed the association between changes in artificially SSB 
consumption, as well as baseline SSB consumption and the incidence of the MS. 
P values were based on two-tailed test and p values less than 0.05 were considered 
statistically significant. 
As sensitivity analyses, we estimated the full-adjusted odds ratios for the fifth quintile 
of change in SSB after modifying several assumptions: a) using ATP-III criteria for MS, 
b) using IDF criteria for MS, c) adopting different limits for allowable total energy 
intake, d) excluding participants with diabetes, cancer or cardiovascular disease at 
baseline. In the same line, we calculated the hazard ratio for the fifth quintile of change 
in SSB using Cox regression models instead of ORs calculated by non-conditional 
logistic regression. 
 
Results 
The baseline characteristics of patients lost to follow-up did not substantially differ 
from those who completed the follow-up (data not shown). The characteristics of 
participants according to their quintiles of change in SSB consumption are presented in 
Table 1. Those participants who increased their SSB consumption the most were more 
likely to be men and presented a lower adherence to the Mediterranean dietary pattern.  
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Incidence of MS 
During a median follow-up of 6 years, we identified 361 incident cases of MS among 
8,157 participants initially free of MS. 
Table 2 shows the incidence of MS according to quintiles of change in SSB 
consumption. After adjusting for age and sex, participants in the highest quintile of 
increase in SSB presented a significant greater risk of developing MS (OR: 2.2; 95%CI: 
1.4-3.4; p for trend 0.003) compared with those in the lowest quintile. This association 
persisted (OR: 2.2; 95%CI: 1.4-3.4; p for trend 0.006) even after adjustment for 
potential confounding factors (baseline BMI, smoking, physical activity, alcohol intake, 
total energy intake, baseline SSB consumption and adherence to the Mediterranean 
dietary pattern). When we repeated the analyses using servings (1 can=330 ml) of 
change, those participants who increased their consumption of SSB during follow-up in 
more than one serving per week increased their risk of developing MS in 101% 
(adjusted OR: 2.01; 95%CI: 1.14-3.55) in comparison with those participants who 
decreased in one serving per week or more their consumption. We did not observe any 
significant interaction between changes in SSB drinks consumption and sex (p: 0.45) or 
age (p: 0.86).  
In the SUN cohort the consumption of SD was very low. Only 405 participants included 
in the analyses (4.9%) consumed one or more servings per day at baseline. When we 
evaluated as a secondary analysis the baseline SSB consumption as exposure instead of 
evaluating change in consumption, we did not find any significant association for 
incidence of MS (data not shown). The consumption of non-sugared SD was even lower 
among the SUN participants. 75% of them never consumed non-sugared SD, and only 
2.8% consumed one or more servings per day. Similarly, we did not find any 
association between baseline non-sugared SD consumption and incidence of MS. 
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As a sensitivity analysis we assessed the association between changes in SSB 
consumption between 6 years of follow-up and baseline (Q6-Q0) and the incidence of 
MS in the 8-year follow-up. We only identified 107 incident cases. We did not observe 
any significant association.  
The association between an increase in the SSB consumption and the risk of MS was 
robust and remained statistically significant in all but one sensitivity analyses (Table 4). 
The only exception was the p for trend when we considered the definition of MS 
according to the ATP-III criteria, a more strict definition. By contrast, when we 
conducted Cox regression models the hazard ratio for the fifth quintile of change in SSB 
was 1.9 (95%CI: 1.2-3.0; p for trend: 0.032) in comparison with the first quintile of 
change in SSB, therefore the association remained statistically significant.  
 
Incidence of individual components of MS 
Table 3 shows the incidence of MS criteria during follow-up according to quintiles of 
change in SSB consumption. Increases in SSB consumption during follow-up were 
associated with higher risk of developing high blood pressure, central obesity, 
hypertriglyceridemia, and impaired fasting glucose. After adjusting for potential 
confounders, participants in the highest quintile of increase in SSB consumption 
presented a significant higher risk of developing the blood pressure criteria (OR: 1.7; 
95%CI: 1.4-2.0; p for trend<0.001), the waist circumference criteria (OR: 1.9; 95%CI: 
1.6-2.2; p for trend<0.001), the TG criteria (OR: 1.6; 95%CI: 1.1-2.2; p for trend: 
0.021) and fasting glucose criteria (OR: 1.4; 95%CI: 1.1-1.9; p for trend: 0.028) in 
comparison with those who decreased their consumption.  
As secondary analyses, when we assessed the association between baseline quintiles of 
SSB consumption and incidence of each criteria of the MS, we found that a higher 
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baseline consumption of SSB was significantly associated with a higher risk of 
developing the waist circumference criteria during follow-up (adjusted OR: 1.18; 
95%CI: 1.01-1.37). We did not find any significant association for other criteria.  
 
Discussion 
In this prospective study of young-middle-aged (mean age: 36 years old) free-living 
Mediterranean university graduates, a small increase in SSB consumption during follow 
up was associated with higher risk of developing MS and with higher risk of developing 
four of its five components: high blood pressure, central obesity, hypertriglyceridemia, 
or impaired fasting glucose.  
Among 8,157 participants included in this study, we observed 361 incident cases of MS. 
This incidence of MS was lower than those described in the general Spanish population
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as it is to be expected in a cohort of young-middle aged adults, with a low baseline BMI 
and a high educational level.  
Our study is partially consistent with previous results found in three prospective cohorts
 
[10-12] that found that SSB consumption was a risk factor for developing MS. 
However, we did not find a direct association between baseline SSB consumption and 
higher risk of developing MS but only for changes in consumption during follow up. 
There are some differences between those studies and our cohort that may explain these 
results. First, in the SUN Project we recruited Spanish university graduates, in the 
Framingham Offspring Study the participants were white Americans [10], in the MESA 
study the participants were Caucasian, African American, Hispanic, and Chinese [11] 
and in the ARIC study the cohort was formed by white and black American [12]. 
Second, our cohort is younger than the other cohorts. Third, in the SUN cohort the 
incidence of MS was 4.4% during 6 years of follow-up, but it was 18.7% after 4-year 
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follow-up in the Framingham Offspring Study, 12.8% in the MESA study after 5-year 
follow-up, and 39.8% after 9-year follow-up in the ARIC study. Finally, the distribution 
of baseline SSB consumption was very different too, and while in the SUN cohort only 
1.1% of participants consumed two or more servings of SSB per day, in the 
Framingham Offspring Study this percentage was 13.8%, in the MESA study 13.6% of 
participants and in the ARIC study a 33% of participants consumed a median of 1 
serving per day. 
Heidemann, et al. [24] found that a dietary pattern high in refined grains, processed 
meat, high-sugar beverages, beer, sweets and cakes, snacks and butter was associated 
with higher prevalence of abdominal obesity, hypertension, hypertriglyceridemia, and 
MS in a cross-sectional study of a nationally representative sample of German adults. 
Interestingly, our results are in accordance with recent results from the CARDIA cohort 
[25] reporting that baseline SSB consumption was associated with several components 
of the MS but not with the incidence of the MS as a whole.  
In spite of the consumption of SSB was low among our participants, we found that a 
relatively small increase in SSB consumption (more than one serving –330 ml- per 
week) was associated with a significantly higher risk of developing MS and its 
conditions in comparison with participants who decreased their consumption more than 
one serving per week. In fact, changes from repeated measurements of dietary habits 
controlling for baseline exposure are useful in assessing the effects of changes in dietary 
intakes over time on the development of chronic diseases such as MS in a cohort study 
[26]. This is a methodological strength of our assessment. 
There are different mechanisms that can explain the higher risk of MS associated with 
greater SSB consumption. Larger consumption of added sweeteners such as high 
fructose corn syrup can lead to weight gain, insulin resistance [27], a lowering of HDL-
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cholesterol [9], and an increase in triglyceride levels [8]. Consumption of liquids is 
associated with a lesser degree of dietary compensation (the adjustment in energy intake 
made in subsequent meals in response to food intake) [28]. 
Individuals with greater intake of SSB have also a dietary pattern characterized by 
lower consumption of fiber and dairy products, and a more sedentary lifestyle [24]. 
Nonetheless, in the present study, we adjusted for total energy intake, smoking, physical 
activity, alcohol intake and adherence to a Mediterranean dietary pattern in 
multivariable analyses and still we observed a significant association between changes 
in SSB consumption and the risk of developing MS and its component criteria. It is 
conceivable, though, that because of the observational nature of our study, we cannot 
completely rule out residual confounding caused by lifestyle factors not adjusted for in 
the present analyses.  
Our participants are not representative of the general Spanish population. We restricted 
our cohort to highly educated participants to obtain a good quality of self-reported 
information, to improve the retention rate and to prevent confounding by educational 
level, and therefore, by socio-economic status [29].  
Inherent to the nutritional epidemiology methods, we have to point out the possibility of 
some degree of misclassification in the dietary assessment. However, we have used a 
FFQ previously validated in Spain [20]. In addition, we would expect this 
misclassification to be non-differential and, therefore, it may drive the association 
toward the null value.  
Our study has important strengths such as the repeated measurement of the dietary 
exposure, the large number of participants, the long follow-up period, the previously 
published validation studies assessing the validity of our methods, the ability to control 
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for an important number of potential confounders, and the good quality of the self-
reported data of our highly-educated volunteers.  
In summary, even a relatively small increase in SSB consumption was associated with 
higher risk of developing MS and metabolic disorders in a cohort of young-middle-aged 
Spanish university graduates. However, since the incidence of MS was low, further 
studies should be conducted to confirm these findings.  
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Table 1. Baseline characteristics of participants according to quintiles (Q) of 
change in Sugar-Sweetened Beverages (SSB) Consumption. 
 Q 1 Q 2 Q 3 Q 4 Q 5 
N 1890 1334 1796 1626 1511 
Change in SSB (ml/day) ≤-28.57 -28.58 to <0 0 >0 to 33.81 >33.81 
Age (years) 31.4 (8.4) 34.9 (9.7) 41.2 (11.5) 36.7 (10.1) 34.5 (10.1) 
Women (%) 65.6 71.4 74.0 64.1 51.4 
Alcohol consumption (g/d) 6.4 (8.2) 4.9 (7.7) 5.7 (9.5) 5.1 (6.9) 6.8 (8.9) 
Baseline SSB consumption 
(ml/d) 
109.6 
(119.8) 
26.53  (35.1) 0 (NA) 13.5 (9.9) 58.6 (80.6) 
Baseline BMI (kg/m
2
) 22.5 (2.8) 22.5 (2.7) 22.7 (2.7) 22.6 (2.7) 23.0 (2.9) 
Leisure-time physical activity 
(METs-h/week) 
19.7 (2.7) 19.0 (20.4) 20.4 (21.4) 20.8 (23.4) 20.3 (23.8) 
Total energy intake (kcal/day) 2472.3 
(604.6) 
2367.8 
(575.9) 
2222.1 
(606.8) 
2331.2 
(585.1) 
2464.1 
(633.6) 
Mediterranean diet adherence
a
 3.8 (1.7) 4.0 (1.8) 4.4 (1.8) 4.0 (1.8) 1.7 (1.7) 
Current smokers (%) 30.7 23.1 18.9 20.0 27.2 
Former smokers (%) 19.6 24.4 33.8 26.1 23.6 
Snacking between meals (%) 43.9 35.1 29.5 31.0 36.0 
Television watching (h/week) 5.6 (4.3) 5.8 (4.3) 6.0 (4.4) 5.9 (4.4) 5.9 (4.4) 
Continuous variables are expressed as means and (standard deviations). Categorical 
variables are expressed as percentages.  
NA: Not applicable 
a
Score proposed by Trichopoulou
20 
Table(s)
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Q1-Q5: quintiles of change in SSB consumption 
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Table 2. Odds Ratios (OR) (95% CI) of incident MS according to Quintiles (Q) of 
change in Sugar-Sweetened Beverages (SSB) Consumption. The SUN Project 1999-
2011. 
 Q1 Q2 Q3 Q4 Q5 p for trend 
n 1890 1334 1796 1626 1511  
Changes 
(servings
a
/wk; 
median) 
-1.35 -0.3 0 +0.4 +2.4  
Changes (ml/day) -28.57 -28.58 to <0 0 >0 to 33.81 >33.81  
MS incidence 33 (1.7%) 59 (4.4%) 105 (5.8%) 83 (5.1%) 81 (5.4%)  
Crude OR 1 (Ref.) 2.6 (1.7-4.0) 3.5 (2.3-5.2) 3.0 (2.0-4.6) 3.2 (2.1-4.8) <0.001 
Age-sex adjusted 
OR 
1 (Ref.) 2.2 (1.4-3.5) 1.9 (1.3-3.0) 2.2 (1.4-3.3) 2.2 (1.4-3.4) 0.003 
Multivariate
b
 
adjusted OR 
1 (Ref.) 2.2 (1.4-3.6) 1.9 (1.2-3.0) 2.2 (1.4-3.5) 2.2 (1.4-3.4) 0.006 
a
1 serving: 330 ml 
b
Adjusted for age, sex, baseline BMI, smoking, physical activity, alcohol intake, basal 
soft drink intake, total energy intake and adherence to the Mediterranean dietary pattern 
(Score proposed by Trichopoulou
20
).  
Q1-Q5: quintiles of change in SSB consumption. 
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Table 3. Odds Ratios (OR) (95% CI) of incident MS criteria according to Quintiles 
(Q) of change in Sugar-Sweetened Beverages (SSB) Consumption. The SUN 
Project 1999-2011. 
 Q1 Q2 Q3 Q4 Q5 p for trend 
N 1890 1334 1796 1626 1511  
Changes (servings
a
/wk; 
median) 
-1.35 -0.3 0 +0.4 +2.4  
Changes (ml/day) -28.57 -28.58 to <0 0 0 to 33.81 >33.81  
Blood pressure 
criteria  
      
Incident cases 227 235 363 311 328  
Crude OR 1 (Ref.) 1.6 (1.3-1.9) 1.9 (1.5-2.2) 1.7 (1.4-2.1) 2 (1.7-2.4) <0.001 
Age-sex adjusted OR 1 (Ref.) 1.3 (1.1-1.7) 1.2 (0.9-1.4) 1.3 (1.1-1.5) 1.6 (1.3-1.9) <0.001 
Multivariate
b
 adjusted 
OR 
1 (Ref.) 1.5 (1.2-1.9) 1.3 (1.1-1.6) 1.4 (1.2-1.8) 1.7 (1.4-2.0) <0.001 
Waist criteria       
Incident cases 688 550 749 771 770  
Crude OR 1 (Ref.) 1.2 (1.1-1.4) 1.2 (1.1-1.4) 1.6 (1.4-1.8) 1.8 (1.6-2.1) <0.001 
Age-sex adjusted OR 1 (Ref.) 1.1 (0.9-1.2) 0.8 (0.7-1.0) 1.3 (1.1-1.5) 1.6 (1.4-1.9) <0.001 
Multivariate
b
 adjusted 
OR 
1 (Ref.) 1.2 (1.0-1.5) 1.0 (0.8-1.2) 1.7 (1.4-2.0) 1.9 (1.6-2.2) <0.001 
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Table 3 (cont.). Odds Ratios (OR) (95% CI) of incident MS criteria according to 
Quintiles (Q) of change in Sugar-Sweetened Beverages (SSB) Consumption. The 
SUN Project 1999-2011. 
 Q1 Q2 Q3 Q4 Q5 p for trend 
HDL criteria        
Incident cases 86 68 89 97 74  
Crude OR 1 (Ref.) 1.1 (0.8-1.6) 1.1 (0.8-1.5) 1.3 (1.0-1.8) 1.1 (0.8-1.5) 0.6 
Age-sex adjusted OR 1 (Ref.) 1.0 (0.7-1.5) 0.9 (0.7-1.3) 1.2 (0.9-1.7) 1.1 (0.8-1.5) 0.6 
Multivariate
b
 adjusted 
OR 
1 (Ref.) 1.1 (0.8-1.6) 1.0 (0.7-1.5) 1.3 (1.0-1.9) 1.1 (0.8-1.5) 0.5 
Triglycerides criteria        
 
Incident cases 
68 75 109 91 98  
Crude OR 1 (Ref.) 1.6 (1.1-2.2) 1.7 (1.3-2.4) 1.6 (1.1-2.2) 1.9 (1.3-2.5) 0.001 
Age-sex adjusted OR 1 (Ref.) 1.4 (1.0-2.0) 1.2 (0.9-1.7) 1.3 (0.9-1.8) 1.5  (1.1-2.1) 0.018 
Multivariate
b
 adjusted 
OR 
1 (Ref.) 1.5 (1.1-2.2) 1.3 (0.9-1.9) 1.4 (1.0-1.9) 1.6 (1.1-2.2) 0.021 
Fasting glucose 
criteria  
      
Incident cases 105 101 198 161 146  
Crude OR 1 (Ref.) 1.4 (1.1-1.8) 2.1 (1.6-2.7) 1.9 (1.4-2.4) 1.8 (1.4-2.4) <0.001 
Age-sex adjusted OR 1 (Ref.) 1.2 (0.9-1.6) 1.3 (1.0-1.7) 1.4 (1.1-1.8) 1.4 (1.1-1.8) 0.022 
Multivariate
b
 adjusted 
OR 
1 (Ref.) 1.3 (0.9-1.7) 1.4 (1.0-1.9) 1.5 (1.1-2.0) 1.4 (1.1-19) 0.028 
a
1 serving: 330 ml 
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b
Adjusted for age, sex, baseline BMI, smoking, physical activity, alcohol intake, basal 
soft drink intake, total energy intake and adherence to the Mediterranean dietary pattern 
(Score proposed by Trichopoulou
20
).  
Q1-Q5: quintiles of change in SSB consumption. 
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Table 4. Sensitivity analyses. Multivariate-adjusted odds ratio (OR) and 95% 
confidence intervals (95%CI) of metabolic syndrome (MS) for the highest quintile 
of change (Q5) in Sugar-Sweetened Beverages (SSB) Consumption taking as the 
reference category the first quintile (Q1) of change in SSB under several 
assumptions. The SUN Project 1999-2011. 
 n MS (%) OR (95% CI)
 a
 p for trend 
Using ATP-III criteria for MS 8157 214 (2.62%) 1.74 (1.00-3.02) 0.172 
Using IDF criteria for MS 8157 338 (4.14%) 2.22 (1.36-3.58) 0.008 
Energy limits: percentiles 5 to 95 8234 356 (4.00%) 2.35 (1.48-3.74) 0.008 
Energy limits: percentiles 1 to 99 8906 338 (4.10%) 2.30 (1.47-3.60) 0.005 
Excluding participants with 
diabetes, cancer, or cardiovascular 
disease at baseline. 
7996 347 (4.34%) 2.12 (1.29-3.40) 0.010 
 
a
Adjusted for age, sex, baseline BMI, smoking, physical activity, alcohol intake, basal soft 
drink intake, total energy intake and adherence to the Mediterranean dietary pattern (Score 
proposed by Trichopoulou et al
20
).  
 
 
 
 
